1. Home
  2. RJET vs IMMX Comparison

RJET vs IMMX Comparison

Compare RJET & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RJET

Republic Airways Holdings Inc.

N/A

Current Price

$19.56

Market Cap

830.1M

Sector

N/A

ML Signal

N/A

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

N/A

Current Price

$7.69

Market Cap

784.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RJET
IMMX
Founded
1982
2014
Country
United States
United States
Employees
8400
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
830.1M
784.8M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
RJET
IMMX
Price
$19.56
$7.69
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $24.43
AVG Volume (30 Days)
59.2K
★ 1.3M
Earning Date
10-29-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 15.43
N/A
EPS
★ 1.26
N/A
Revenue
★ $1,676,500,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.88
★ N/A
Revenue Growth
★ 13.74
N/A
52 Week Low
$1.33
$2.85
52 Week High
$26.70
$15.10

Technical Indicators

Market Signals
Indicator
RJET
IMMX
Relative Strength Index (RSI) 64.27 30.35
Support Level $18.43 N/A
Resistance Level $19.44 $9.04
Average True Range (ATR) 0.81 0.54
MACD 0.40 0.03
Stochastic Oscillator 75.68 7.80

Price Performance

Historical Comparison
RJET
IMMX

About RJET Republic Airways Holdings Inc.

Republic Airways Holdings Inc is a regional airline mainly in North America. The company provides scheduled passenger service through its mainline partnerships with American Airlines, Delta Air Lines, and United Airlines. Republic offers scheduled passenger service on several daily flights to various cities in the United States, Canada, Mexico, and the Caribbean. It exclusively operates the dual-class Embraer E170/175 family of aircraft, and provides its services under the American Eagle, Delta Connection, or United Express brands. The company is organized and operates as one operating and reportable segment: regional airline services.

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

Share on Social Networks: